NUNNARI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 9.935
AS - Asia 5.887
EU - Europa 5.612
SA - Sud America 2.533
AF - Africa 180
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.162
Nazione #
US - Stati Uniti d'America 9.651
SG - Singapore 2.620
BR - Brasile 2.258
IE - Irlanda 1.825
CN - Cina 1.483
SE - Svezia 1.078
IT - Italia 920
HK - Hong Kong 777
PL - Polonia 514
VN - Vietnam 416
RU - Federazione Russa 265
DE - Germania 251
FR - Francia 179
CA - Canada 153
FI - Finlandia 143
GB - Regno Unito 122
IN - India 115
AR - Argentina 101
MX - Messico 82
AT - Austria 72
IQ - Iraq 65
BD - Bangladesh 64
TR - Turchia 62
UA - Ucraina 51
EC - Ecuador 50
ZA - Sudafrica 50
ID - Indonesia 48
MA - Marocco 46
NL - Olanda 35
UZ - Uzbekistan 35
BE - Belgio 31
PK - Pakistan 29
CO - Colombia 28
CI - Costa d'Avorio 27
LT - Lituania 24
VE - Venezuela 24
ES - Italia 23
CZ - Repubblica Ceca 20
JP - Giappone 19
PY - Paraguay 18
EG - Egitto 17
NP - Nepal 17
KR - Corea 16
CL - Cile 14
JO - Giordania 14
PE - Perù 14
BO - Bolivia 13
UY - Uruguay 12
TN - Tunisia 11
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
DZ - Algeria 9
HN - Honduras 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CH - Svizzera 8
KG - Kirghizistan 8
TH - Thailandia 8
AL - Albania 7
JM - Giamaica 7
KE - Kenya 7
KZ - Kazakistan 7
LK - Sri Lanka 7
PA - Panama 7
BG - Bulgaria 6
AM - Armenia 5
GE - Georgia 5
IL - Israele 5
LU - Lussemburgo 5
OM - Oman 5
BN - Brunei Darussalam 4
CR - Costa Rica 4
GT - Guatemala 4
IR - Iran 4
LB - Libano 4
MD - Moldavia 4
PT - Portogallo 4
RO - Romania 4
BF - Burkina Faso 3
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
KW - Kuwait 3
MY - Malesia 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SN - Senegal 3
BB - Barbados 2
CG - Congo 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 24.139
Città #
Dublin 1.825
Dallas 1.384
Chandler 1.362
Singapore 1.252
Ashburn 1.002
Hong Kong 775
Nyköping 743
Beijing 634
Warsaw 503
Princeton 433
Dearborn 384
Jacksonville 313
Medford 301
Des Moines 247
Messina 216
Los Angeles 208
The Dalles 199
São Paulo 176
Ann Arbor 173
Boardman 165
New York 143
Buffalo 137
Wilmington 127
Redondo Beach 122
Ho Chi Minh City 119
Moscow 113
Houston 94
Ottawa 89
Hanoi 79
Rome 77
Jinan 76
Munich 75
Belo Horizonte 74
Dong Ket 74
Tianjin 74
Cambridge 68
Shenyang 67
Nuremberg 63
Rio de Janeiro 61
Helsinki 58
Seattle 58
Nanjing 56
San Mateo 53
Pune 48
Falls Church 47
Curitiba 39
Milan 38
Porto Alegre 37
Brasília 36
Vienna 36
Tashkent 33
Guangzhou 32
Woodbridge 32
Brussels 31
Santa Clara 31
Frankfurt am Main 30
Bremen 29
Brooklyn 29
Catania 29
Zhengzhou 29
Campinas 28
Hangzhou 28
Johannesburg 28
Norwalk 28
Turku 28
Abidjan 27
Baghdad 27
Chennai 27
Guarulhos 27
Mexico City 26
Redwood City 26
Denver 25
Haikou 25
Caltagirone 24
Goiânia 23
Hebei 23
Jakarta 23
Montreal 23
Phoenix 22
London 21
Toronto 21
Contagem 19
Salvador 19
Taizhou 19
Nanchang 18
Philadelphia 18
San Francisco 18
Boston 17
Guayaquil 17
Orem 17
Stockholm 17
Tokyo 17
Fairfield 16
Fortaleza 16
Istanbul 16
Sorocaba 16
Atlanta 15
Casablanca 15
Dhaka 15
Manaus 15
Totale 15.688
Nome #
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 426
Awareness and perception of accurancy of the Undetectable=Untransmittable (U=U) message in people living with HIV/AIDS (PLWHA), in Italy and correlation with the level of confidence in reference physicians. 265
Durability of F/TAF-based regimens in a large cohort of PLWH seen of care in Italy 231
Impact of multi-drug resistance on mortality: a multi-cohort Italian study. 224
Anal cancer in people living with HIV: the importance of the screening and of early diagnosis 194
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 191
Breast cancer in women living with HIV 183
MALATTIE INFETTIVE E TROPICALI PER STUDENTI E MEDICI DI MEDICINA GENERALE 167
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. 151
Contribution of naive CD4+T cells to the intact HIV reservoir 145
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals 144
Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy 141
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 137
Epidemiologia delle farmacoresistenze di HIV nella regione Sicilia 134
Anxiety disorders and adherence to HAART 133
Circulating angiopoietin‑like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 128
Sindrome di Castelman in paziente affetto da HIV e con sospetto Sarcoma di Kaposi. 128
Acetyl-L-carnitine supplementation during HCV therapy with pegylated interferon-α 2b plus ribavirin: Effect on work performance; a randomized clinical trial 126
Ocular surface manifestation of COVID-19 and tear film analysis 126
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 125
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 125
Epidemiologia delle farmacoresistenza di HIV nella Regione Sicilia. 120
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 119
Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review 118
Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs 116
Malignant melanoma in HIV: epidemiology, pathogenesis and management 116
Prostate cancer in HIV-positive patients: a review of the literature 115
HIV and Colorectal Cancer. New Insights and Review of the Literature 111
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudina/Dolutegravir Therapy in Human Immunodeficiency Virus Treatment-Experienced Patients. 111
ANAL CANCER IN HIV-POSITIVE PATIENTS 111
Achromobacter xylosoxidans meningitis in an immunosuppressed patient 110
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 109
Sexual dysfunction and anxiety in HIV-1-infected males in Eastern Sicily. 109
Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient 109
Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients 108
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 108
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 107
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate 106
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience 106
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 105
Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis 103
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives 102
Comparative neuropsychiatric toxicity profile of dolutegravir versus efavirenz versus other antiretroviral third drugs used either in first-line or switching antiretroviral therapies (ART): data from ICONA Foundation Study Cohort 102
Transmission mode associated with coronavirus disease 2019: a review 102
Epatite A: immunità e accettazione della profilassi vaccinale in una coorte siciliana di pazienti con infezione da HIV. Dati preliminari. 101
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 100
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 100
Comparative neuropsychiatric toxicity profile of dolutegravir (DGT)-based versus efavirenz (EFV)-based versus other recommend first-line antiretroviral therapies (ART): data from ICONA Foundation Study Cohort. 98
Factors Associated With Weight Gain in People Treated With Dolutegravir 98
ANALYSIS OF IMPEDIMENTS TO THE MAINTENANCE IN CARE OF PEOPLE WITH HIV IN ITALY 97
Health status and Quality of life in people living with HIV (PLWH): results from the ICONA cohort 97
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of late diagnosis 97
Tache Noire in a Patient with Acute Q Fever 97
Methicillin‑sensitive Staphylococcus aureus prosthetic vascular graft infection after a Fontan procedure in an adult patient: A case report 97
Ampicillin plus ceftriaxone regimen against enterococcus faecalis endocarditis: A literature review 96
HIV and Mediterranean Zoonoses: A Review of the Literature 95
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: Review of the literature and suggestions for a friendly use 94
Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a university hospital of south Italy 94
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 94
Pityriasis rosea during etanercept therapy. 93
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 93
The new era of vaccines: the “nanovaccinology” 93
Cervical and lumbar diffuse Brucella spondylodiscitis: an uncommon case report 93
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 92
Acute non A-E hepatitis in eastern Sicily: the natural history and the role of hepatitis G virus. 92
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? 92
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 92
HPV AND URINARY BLADDER CARCINOMA: A REVIEW OF THE LITERATURE 91
null 91
Acute asthma in children: treatment in emergency. 91
New and old assumptions of lung cancer in people living with HIV 90
Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis 90
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 90
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 90
Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis 89
Acute Glomerulonephritis in a Child with Chlamydia pneumoniae Infection: A Case Report 89
Effect of simplification to INSTI-based dual therapy on residual inflammation and viral reservoir 89
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 89
COVID-19 and pregnancy: clinical outcomes and scientific evidence about vaccination 89
Acoustic Radial Force Impulse as an effective tool for a prompt and reliable diagnosis of hepatocellular carcinoma - Preliminary data 88
How Much Does HIV Positivity Affect the Presence of Oral HPV? A Molecular Epidemiology Survey 88
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 88
Nail pigmentation and fatigue. 87
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 87
Definition of a novel vaccination pathway in PLWHA: experience of a Southern University Hospital 87
Are HIV/HCV co.infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study. 86
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 86
Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial 85
The role of the hospital environment in the healthcare-associated infections: a general review of the literature 85
HIV-RNA CD4/CD8 ratio and HDL concentration in a cohort of HIV + ART-naïve patients. 84
Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC 84
Atypical presentation of herpes simplex virus 1 encephalitis in pediatric age 84
Incidence and risk factors for liver enzyme elevation among naïve HIV-1 infected patients receiving ART in the ICONA cohort 83
The good, the bad and the ugly: Determinants of antiretroviral-associated toxicities 82
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 82
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 82
null 81
Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies 81
Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19 81
Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. 80
Totale 11.191
Categoria #
all - tutte 111.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 0 0 0 117 136 110 104 126 71 108
2021/20222.099 36 146 28 88 129 45 163 108 64 104 272 916
2022/20235.538 710 344 187 466 396 510 98 325 2.248 29 159 66
2023/20241.200 149 205 110 101 79 212 32 53 9 30 18 202
2024/20256.231 98 79 116 442 421 103 163 1.173 1.922 337 519 858
2025/20266.344 721 1.271 1.623 1.168 1.382 179 0 0 0 0 0 0
Totale 25.734